Enolase inhibitors as therapeutic leads for Naegleria fowleri infection is a research paper published in PLoS Pathogens (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21AI175463, P20GM146584 and P20GM113226
NIH
Grant: R01CA231509
NIH
Grant: 75N93022C00036
NIGMS NIH HHS
Grant: P20 GM113226
NIGMS NIH HHS
Grant: P20 GM146584
NIAID NIH HHS
Grant: R21 AI175463
NIH HHS
Grant: S10 OD020106
NIAID NIH HHS
Grant: R21 AI171217
National Institutes of Health
Grant: 1R21AI175463-01
Approaches for genetic manipulation of Naegleria fowleri
National Institutes of Health
Grant: 3P20GM146584-02S1
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
National Institutes of Health
Grant: 1R01CA231509-01A1
Pro-Drug Enolase Inhibitors in Precision Oncology
National Institutes of Health
Grant: 5P20GM113226-07
Hepatobiology and Toxicology COBRE
FWCI
5.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals